A man in Scotland whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven ...

Researchers have uncovered cancer-like genetic mutations in the affected cells of people with scleroderma, pointing the way to potential new ways to treat the debilitating and sometimes fatal skin and ...

SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...

A dad who lost the use of his hands to a rare disease has had them replaced in a world-first operation. Steven Gallagher, 48, suffered scleroderma, a condition where the skin hardens and tightens. He ...

48-year-old Steven Gallagher is thought to be the first person to get a double hand transplant to help with his scleroderma. Reading time 2 minutes A man in the UK appears to be the first person to ...

Scleroderma, also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. It also may cause problems in the blood vessels, internal organs and ...

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known ...

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating ...

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with ...

A man whose hands were left unusable by scleroderma has been given a new lease of life after what is believed to be the world’s first double hand transplant for the condition. Steven Gallagher, 48, ...